A null polymorphism in NQO115,16 has been associated with an increased risk of complications related to metabolic syndrome17,18 and NQO1-null mice develop insulin resistance resulting in a T2D-like phenotype19. The gene discussed is NQO1; the disease is Insulin resistance.